Jan 22,2021

OncoHost Secures $8 Million Series B Funding Round

OncoHost, a global leader in technology involving host response profiling and personalized cancer therapy, has completed a $8 million Series B funding round. The new funding will help advance the company’s AI-powered precision oncology platform.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Feb 22,2021

Carevive Closes Oversubscribed $18M Series C Equity Raise

Carevive Systems (Carevive), the leading oncology-focused health technology company centered on understanding and improving the cancer patient experience, has today announced the completion of a Series C equity investment of $18 million. The oversubscribed $18 million equity round was led by Philips Health Technology Ventures, and also includes Debiopharm Innovation Fund, and OurCrowd’s digital health fund, Qure Ventures, as well as prior investors HLM Venture Partners, LRVHealth, Cerner, and founder Madelyn Trupkin Herzfeld.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Mar 23,2021

Ghana's Redbird raises $1.5M seed to expand access to rapid medical testing in sub-Saharan Africa

Redbird, a Ghanaian health tech startup that allows easy access to convenient testing and ensures that doctors and patients can view the details of those test results at any time, announced today that it has raised a $1.5 million seed investment. Investors who participated in the round include Johnson & Johnson Foundation, Newton Partners (via the Imperial Venture Fund) and Founders Factory Africa. This brings the company’s total amount raised to date to $2.5 million.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
May 19,2021

Vinehealth and University of Surrey awarded £1m grant to trial a support app for patients undergoing cancer treatment

Vinehealth is delighted to announce their partnership with the University of Surrey in securing a £1 million Innovate UK grant to undertake a randomised controlled trial of our cancer companion app.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
May 26,2021

Engine Biosciences expands its digital drug discovery pipeline with $43M round

Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big Pharma incumbents. Engine Biosciences is one of the former, a Singaporean outfit with an expert founding crew and a different approach to the business of finding new therapeutics, and it just raised $43 million in Series A round to keep growing. The $43 million round was led by Polaris Partners, with participation by newcomers Invus and a long list of existing investors.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Dec 08,2021

Vinehealth, offering digital support for cancer patients and SaaS for R&D, gets $5.5M to launch in the US

Vinehealth has raised $5.5 million of investment in our latest seed funding round, led by Talis Capital with participation from previous investors Playfair Capital and Ascension, as well as a number of angel investors. The Compayn said that this investment builds on their CE mark which was achieved in record time earlier this year; a significant regulatory milestone and will help them to further develop their product, scale their team and expand in the US.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 21,2020

OncoHost, RayBiotech Win $1M From BIRD Foundation

OncoHost, global leader in host response profiling for improved personalized cancer therapy, together with its partner RayBiotech, a leading life sciences company developing high-throughput protein detection technologies for biomarker discovery initiatives, announced today the companies have been awarded a $1 million grant from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

FUNDING GRANT

#platform

View Analyst & Ambassador Comments
Go to original news
Apr 23,2020

Paige adds $5M from Goldman Sachs to double down on AI-based cancer therapies

Paige, the Sloan-Kettering spinout that has been building an artificial intelligence platform to improve cancer pathology and subsequently use those insights to develop better drug therapies, has raised an additional $5 million in funding to continue its work commercialising its platform and expanding its research reach, while also getting FDA clearance to launch in hospitals in North America and Europe.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 26,2020

OncoHealth Raises $28 Million Series C Financing Led by Baird Capital

OncoHealth, the leading digital health company focused on the physical, mental and financial complexities of cancer care, and patients with solutions that are purpose-built for oncology, has announced the completion of a Series C funding round of $28M. Baird Capital led the round and joins existing investors Oak HC/FT, McKesson Ventures, and The Blue Venture Fund.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
May 07,2020

Owkin raises $25 million as it builds a secure network for healthcare analysis and research

Imagine a model of collaborative research and development among hospitals, pharmaceutical companies, universities and other research institutions where no one shared any actual data. That’s the dream of the new New York-based startup Owkin, which has raised $25 million in fresh financing from investors in Series A round, including Bpifrance Large Venture, Cathay Innovation and MACSF (the French Pension Fund for Clinicians), alongside previous investors GV, F-Prime Capital and Eight Roads.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING